Interestingly, in breast cancer, studies by Ma et al., showed that miR-9, a microRNA induced by MYC/MYCN, targets E-cadherin, and not only primes cancer cells for epithelial to mesenchymal transition (EMT) and invasion, but also contribute to promoting angiogenesis. This evidence concerns the gene MYCN and cancer.